Prognostic Tests in Early-Stage Hormone Receptor–Positive Breast Cancer: An Opportunity to Refine Personalized Cancer Care
- 1 April 2023
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 41 (10), 1816-1819
- https://doi.org/10.1200/jco.22.02863
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerThe New England Journal of Medicine, 2018
- Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor–Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5Journal of Clinical Oncology, 2018
- Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast CancerJAMA Oncology, 2018
- Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trialsThe Lancet Oncology, 2017
- Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancerAsia-Pacific Journal of Clinical Oncology, 2017
- Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine TherapyJNCI Journal of the National Cancer Institute, 2016
- Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the OthersJNCI Journal of the National Cancer Institute, 2016
- Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapseAnnals of Oncology, 2012
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trialThe Lancet Oncology, 2010
- Development of the 21-Gene Assay and Its Application in Clinical Practice and Clinical TrialsJournal of Clinical Oncology, 2008